Horizon Pharma reported $169.56M in Stock for its fiscal quarter ending in December of 2022.



Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
ALKERMES USD 196.62M 5.63M Dec/2025
Amgen USD 6.22B 121M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
Bausch Health Companies USD 1.6B 57M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Cara Therapeutics USD 900K 0 Mar/2025
Coherus Biosciences USD 3.17M 1.12M Dec/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Merck USD 6.44B 157M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pacira USD 152.86M 4.82M Dec/2025
Perrigo USD 1.15B 78M Dec/2025
Pfizer USD 11.47B 201M Sep/2025
Prestige Brands USD 163.59M 4.6M Dec/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
Takeda JPY 1.41T 107.71B Dec/2025
Xeris Pharmaceuticals USD 68.67M 1.21M Dec/2025
Zoetis USD 2.43B 35M Dec/2025